Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Company Overview - Amgen is focused on serious diseases, particularly in four key areas: heart attack, stroke, cancer, osteoporosis, and rare diseases [3][4] - The company has a portfolio of 38 innovative and biosimilar medicines, each contributing significantly to addressing these serious diseases [4] Community Engagement - Amgen has committed $10 million to support the rebuilding efforts in Southern California following the devastating wildfires [3] Leadership and Presentation - Robert Bradway, Chairman, CEO & President of Amgen, presented at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025 [1][2]